Talis Biomedical Corporation

Talis is developing a new class of diagnostic platform to enable rapid, high-complexity testing across a wide range of healthcare settings.

Testing for COVID-19 is in high demand. Learn more about our product options.

GenBody COVID-19 Ag Test
Minimize disruptions with high-volume SARS-CoV-2 antigen testing and results in 15 minutes
Learn more: https://talisbio.com/genbody-covid-19-antigen-test/

TALIS ONE™ COVID-19 TEST SYSTEM
Rapid point-of-care COVID-19 test that enables highly sensitive SARS-CoV-2 RNA detection from nasal mid-turbinate swabs in less than 30 minutes. With its dual-gene target design, test sensitivity and inclusivity of variants are optimized.
Learn more: https://talisbio.com/talis-one-covid-19-test-system/

Our visionary team combines depth of experience with passion to deliver a pioneering solution to infectious disease diagnostics. Infectious disease treatment today is largely guideline-driven: treat patients with similar symptoms the same. Unfortunately, similar symptoms can often have very different causes. Our tests will enable caregivers to know within minutes, the cause of illness, as well as which medications will be effective for their patient, empowering them to provide individualized care rather than broad, guideline-dictated treatments. From the doctor’s office to the hospital bedside to remote care settings, we are re-defining the treatment of infectious diseases.